Abstract
Glial tumors remain challenging problems for the clinician and researcher. Despite more aggressive therapy, the majority of these tumors recur locally. This review will provide an update on the new strategies being developed to treat gliomas. Advances in our understanding of the biology of glial tumors will provide new targets at which to direct therapy.
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Blood-Brain Barrier / drug effects
-
Blood-Brain Barrier / radiation effects
-
Brain Neoplasms / drug therapy*
-
Brain Neoplasms / pathology
-
Brain Neoplasms / radiotherapy*
-
Carmustine / administration & dosage
-
Cell Division / drug effects
-
Cell Division / radiation effects
-
Cell Survival / drug effects
-
Cell Survival / radiation effects
-
Chemotherapy, Adjuvant
-
Combined Modality Therapy
-
Cranial Irradiation*
-
Glioma / drug therapy*
-
Glioma / pathology
-
Glioma / radiotherapy
-
Humans
Substances
-
Antineoplastic Agents
-
Carmustine